Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma

Publication date: Available online 30 June 2017
Source:Oral Oncology
Author(s): Wim van Boxtel, Eline Boon, Willem L.J. Weijs, Frank J.A. van den Hoogen, Uta E. Flucke, Carla M.L. van Herpen




http://ift.tt/2tvcKoY